Zürcher Kantonal Bank

Type

Bank

Status

Active

Location

Zurich, Switzerland

Total investments

162

Average round size

7M

Portfolio companies

113

Rounds per year

1.05

Lead investments

17

Follow on index

0.30

Exits

2

Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareSaaSRoboticsManufacturingMedical DeviceMedicalPharmaceutical

Summary

Zu00fcrcher Kantonal Bank appeared to be the Corporate Investor, which was created in 1870. The leading representative office of defined Corporate Investor is situated in the Zu00fcrich. The company was established in Europe in Switzerland.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Zu00fcrcher Kantonal Bank, startups are often financed by investiere | Verve Capital Partners, Foundation for Technological Innovation (FIT), Business Angels Switzerland (BAS). The meaningful sponsors for the fund in investment in the same round are StartAngels Network, 3wVentures, Redalpine Venture Partners. In the next rounds fund is usually obtained by investiere | Verve Capital Partners, Zu00fcrcher Kantonalbank ZKB, OCCIDENT.

The common things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 1 percentage points less often commits exit comparing to other organizations. When the investment is from Zu00fcrcher Kantonal Bank the average startup value is 5-10 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight GetYourGuide, MerLion Pharma, Stokes Bio. Among the most successful fund investment fields, there are Medical, Information Technology.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
162
Lead investments
17
Exits
2
Rounds per year
1.05
Follow on index
0.30
Investments by industry
  • Health Care (45)
  • Medical Device (43)
  • Biotechnology (35)
  • Medical (27)
  • Software (26)
  • Show 150 more
Investments by region
  • Switzerland (155)
  • United Kingdom (2)
  • Singapore (2)
  • Spain (1)
  • Germany (1)
  • Show 1 more
Peak activity year
2020
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
17M
Group Appearance index
0.87
Avg. company exit year
9
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ARTIRIA Medical 28 Feb 2024 Biotechnology, Health Care Early Stage Venture 6M Switzerland, Vaud, Lausanne
DataHow 28 May 2024 Early Stage Venture Switzerland, Zurich, Zurich
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.